Cleared Traditional

K230887 - Sysmex XQ-Series (XQ-320) Automated Hem...

K230887 is the FDA 510(k) clearance for Sysmex XQ-Series (XQ-320) Automated Hem... by Sysmex America, Inc.. It is a Class 2 Hematology device (product code GKZ) cleared through the Traditional 510(k) pathway after a 265-day FDA review.

K230887 · Sysmex America, Inc. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2023
Decision
265d
Days
Class 2
Risk

K230887 is an FDA 510(k) clearance for the Sysmex XQ-Series (XQ-320) Automated Hematology Analyzer. Classified as Counter, Differential Cell (product code GKZ), Class II - Special Controls.

Submitted by Sysmex America, Inc. (Lincolnshire, US). The FDA issued a Cleared decision on December 21, 2023 after a review of 265 days - an extended review cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5220 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all Sysmex America, Inc. devices

Submission Details

510(k) Number K230887 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 31, 2023
Decision Date December 21, 2023
Days to Decision 265 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
152d slower than avg
Panel avg: 113d · This submission: 265d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GKZ Counter, Differential Cell
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5220
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GKZ Counter, Differential Cell

All 193
Devices cleared under the same product code (GKZ) and FDA review panel - the closest regulatory comparables to K230887.
UniCel DxH 900 Coulter Cellular Analysis System
K240252 · Beckman Coulter, Inc. · Jul 2024
Yumizen H2500
K232946 · HORIBA ABX SAS · May 2024
HemoScreen Hematology Analyzer
K240636 · Pixcell Medical Technologies · May 2024
QScout Lab
K230878 · Ad Astra Diagnostics, Inc. · Nov 2023
HemoScreen Hematology Analyzer
K222148 · Pixcell Medical Technologies, Ltd. · Aug 2023
Alinity h-series System
K220031 · Abbott Laboratories · Aug 2023